| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.52e-14 | 100 | 118 | 13 | GO:0030527 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CREB3L3 H2BC12 | 9.90e-08 | 398 | 118 | 14 | GO:0046982 |
| GeneOntologyMolecularFunction | structural molecule activity | H2BC11 MXRA5 HLA-DRB1 PCLO H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 PXDN H2BC21 H2BC5 H2BC3 H2BC12 | 1.91e-05 | 891 | 118 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 1.99e-05 | 56 | 118 | 5 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 2.17e-05 | 57 | 118 | 5 | GO:0070279 | |
| GeneOntologyMolecularFunction | phosphoenolpyruvate carboxykinase activity | 3.46e-05 | 2 | 118 | 2 | GO:0004611 | |
| GeneOntologyMolecularFunction | phosphoenolpyruvate carboxykinase (GTP) activity | 3.46e-05 | 2 | 118 | 2 | GO:0004613 | |
| GeneOntologyMolecularFunction | protein dimerization activity | EPRS1 H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 GLDC NPC1L1 MITF H2BC5 H2BC3 CREB3L3 H2BC12 | 2.48e-04 | 1205 | 118 | 18 | GO:0046983 |
| GeneOntologyMolecularFunction | vitamin binding | 3.92e-04 | 161 | 118 | 6 | GO:0019842 | |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 1.33e-08 | 30 | 114 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 2.53e-08 | 122 | 114 | 9 | GO:0006334 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 9.45e-08 | 142 | 114 | 9 | GO:0034728 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | MED20 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 MED23 | 1.37e-07 | 249 | 114 | 11 | GO:0065004 |
| GeneOntologyBiologicalProcess | mucosal immune response | 2.54e-07 | 48 | 114 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 5.19e-07 | 54 | 114 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 7.66e-06 | 85 | 114 | 6 | GO:0019731 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MED20 H2BC11 PHF20 CDY1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 BUB1 H2BC3 CDYL CDY2A MED23 HCFC1 | 9.07e-06 | 999 | 114 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 9.64e-06 | 134 | 114 | 7 | GO:0061844 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2BC11 CDY1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 BUB1 H2BC3 CDYL CDY2A HCFC1 | 1.43e-05 | 741 | 114 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | propionate catabolic process | 3.03e-05 | 2 | 114 | 2 | GO:0019543 | |
| GeneOntologyBiologicalProcess | glycerol biosynthetic process from pyruvate | 3.03e-05 | 2 | 114 | 2 | GO:0046327 | |
| GeneOntologyBiologicalProcess | chromatin organization | H2BC11 PHF20 CDY1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 BUB1 H2BC3 CDYL CDY2A HCFC1 | 3.36e-05 | 896 | 114 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | cilium organization | RPGRIP1 CWH43 STIL BBS9 KIF3A TBC1D24 BBS10 ENO4 ADAMTS16 SGSM3 SPAG17 | 6.69e-05 | 476 | 114 | 11 | GO:0044782 |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 7.91e-05 | 186 | 114 | 7 | GO:0019730 | |
| GeneOntologyBiologicalProcess | lipoprotein catabolic process | 1.06e-04 | 17 | 114 | 3 | GO:0042159 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | ABAT ACADL ERAP1 SPTLC2 LYPLA2 AKR1A1 WNK1 GGT1 MET PXDN PPT1 ERAP2 EHMT2 GLDC AASS CTSD PCK1 PCK2 | 1.73e-04 | 1253 | 114 | 18 | GO:0044248 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | PDXDC1 ABAT CAD ACADL LYPLA2 AKR1A1 GGT1 ENO4 RIMKLB GLDC AASS AACS SIK2 GPAT4 PCK1 PCK2 | 1.81e-04 | 1035 | 114 | 16 | GO:0019752 |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 1.87e-04 | 150 | 114 | 6 | GO:0050830 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | PDXDC1 ABAT CAD ACADL LYPLA2 AKR1A1 GGT1 ENO4 RIMKLB GLDC AASS AACS SIK2 GPAT4 PCK1 PCK2 | 2.32e-04 | 1058 | 114 | 16 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | PDXDC1 ABAT CAD ACADL LYPLA2 AKR1A1 GGT1 ENO4 RIMKLB GLDC AASS AACS SIK2 GPAT4 PCK1 PCK2 | 2.48e-04 | 1064 | 114 | 16 | GO:0006082 |
| GeneOntologyBiologicalProcess | propionate metabolic process | 3.00e-04 | 5 | 114 | 2 | GO:0019541 | |
| GeneOntologyBiologicalProcess | glycerol biosynthetic process | 3.00e-04 | 5 | 114 | 2 | GO:0006114 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 3.46e-04 | 25 | 114 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | humoral immune response | 4.16e-04 | 321 | 114 | 8 | GO:0006959 | |
| GeneOntologyBiologicalProcess | alditol biosynthetic process | 4.48e-04 | 6 | 114 | 2 | GO:0019401 | |
| GeneOntologyCellularComponent | nucleosome | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.78e-13 | 138 | 117 | 13 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | SOX3 H2BC11 PHF20 H2BC18 H2BC12L H2BC13 H2BC15 TOX4 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 MITF H2BC5 H2BC3 PDS5A CREB3L3 HCFC1 H2BC12 | 6.74e-05 | 1480 | 117 | 21 | GO:0000785 |
| Domain | HISTONE_H2B | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.70e-22 | 21 | 113 | 12 | PS00357 |
| Domain | Histone_H2B | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.70e-22 | 21 | 113 | 12 | IPR000558 |
| Domain | H2B | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.70e-22 | 21 | 113 | 12 | SM00427 |
| Domain | Histone_H2A/H2B/H3 | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.91e-16 | 56 | 113 | 12 | IPR007125 |
| Domain | Histone | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.91e-16 | 56 | 113 | 12 | PF00125 |
| Domain | Histone-fold | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.95e-14 | 83 | 113 | 12 | IPR009072 |
| Domain | - | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.29e-13 | 69 | 113 | 11 | 1.10.20.10 |
| Domain | PyrdxlP-dep_Trfase | 4.67e-06 | 41 | 113 | 5 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 4.67e-06 | 41 | 113 | 5 | IPR015421 | |
| Domain | PEP_carboxykin_GTP_CS | 3.63e-05 | 2 | 113 | 2 | IPR018091 | |
| Domain | PEPCK | 3.63e-05 | 2 | 113 | 2 | PF00821 | |
| Domain | PEP_carboxykinase_GTP | 3.63e-05 | 2 | 113 | 2 | IPR008209 | |
| Domain | PEPCK_GTP | 3.63e-05 | 2 | 113 | 2 | PS00505 | |
| Domain | PEP_carboxykinase_N | 3.63e-05 | 2 | 113 | 2 | IPR008210 | |
| Domain | PEP_carboxykinase_C | 3.63e-05 | 2 | 113 | 2 | IPR013035 | |
| Domain | - | 3.63e-05 | 2 | 113 | 2 | 3.90.228.20 | |
| Domain | - | 3.63e-05 | 2 | 113 | 2 | 3.40.449.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 6.44e-05 | 36 | 113 | 4 | IPR015422 | |
| Domain | - | 8.87e-05 | 39 | 113 | 4 | 3.40.640.10 | |
| Domain | ECH_1 | 1.38e-04 | 17 | 113 | 3 | PF00378 | |
| Domain | Crotonase_core_superfam | 1.38e-04 | 17 | 113 | 3 | IPR001753 | |
| Domain | ZINC_PROTEASE | 3.22e-04 | 98 | 113 | 5 | PS00142 | |
| Domain | Chromo | 5.07e-04 | 26 | 113 | 3 | PF00385 | |
| Domain | AA_TRANSFER_CLASS_2 | 5.36e-04 | 6 | 113 | 2 | PS00599 | |
| Domain | Aminotrans_II_pyridoxalP_BS | 5.36e-04 | 6 | 113 | 2 | IPR001917 | |
| Domain | CHROMO_1 | 6.33e-04 | 28 | 113 | 3 | PS00598 | |
| Domain | CHROMO_2 | 6.33e-04 | 28 | 113 | 3 | PS50013 | |
| Domain | Chromodomain-like | 9.41e-04 | 32 | 113 | 3 | IPR016197 | |
| Domain | ERAP1-like_C_dom | 9.92e-04 | 8 | 113 | 2 | IPR024571 | |
| Domain | ERAP1_C | 9.92e-04 | 8 | 113 | 2 | PF11838 | |
| Domain | Chromo/shadow_dom | 1.03e-03 | 33 | 113 | 3 | IPR000953 | |
| Domain | CHROMO | 1.03e-03 | 33 | 113 | 3 | SM00298 | |
| Domain | - | 1.23e-03 | 35 | 113 | 3 | 3.90.1150.10 | |
| Domain | Chromo_dom_subgr | 1.58e-03 | 10 | 113 | 2 | IPR017984 | |
| Domain | Pep_M12B_propep | 1.68e-03 | 39 | 113 | 3 | PF01562 | |
| Domain | Peptidase_M12B_N | 1.68e-03 | 39 | 113 | 3 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 1.81e-03 | 40 | 113 | 3 | PS00427 | |
| Domain | Reprolysin | 1.81e-03 | 40 | 113 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 1.81e-03 | 40 | 113 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.81e-03 | 40 | 113 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 1.81e-03 | 40 | 113 | 3 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 1.94e-03 | 41 | 113 | 3 | PS00546 | |
| Domain | Disintegrin_dom | 1.94e-03 | 41 | 113 | 3 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 2.23e-03 | 43 | 113 | 3 | IPR001818 | |
| Domain | Peptidase_M1 | 2.30e-03 | 12 | 113 | 2 | IPR001930 | |
| Domain | Peptidase_M1_N | 2.71e-03 | 13 | 113 | 2 | IPR014782 | |
| Domain | - | 2.71e-03 | 13 | 113 | 2 | 3.40.50.20 | |
| Domain | Peptidase_M1 | 2.71e-03 | 13 | 113 | 2 | PF01433 | |
| Domain | ATP_GRASP | 3.15e-03 | 14 | 113 | 2 | PS50975 | |
| Domain | PLAC | 3.15e-03 | 14 | 113 | 2 | PF08686 | |
| Domain | ATP-grasp | 3.15e-03 | 14 | 113 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 3.15e-03 | 14 | 113 | 2 | IPR016185 | |
| Domain | - | 3.62e-03 | 15 | 113 | 2 | 3.30.1490.20 | |
| Domain | Aminotran_1_2 | 4.65e-03 | 17 | 113 | 2 | PF00155 | |
| Domain | Aminotransferase_I/II | 4.65e-03 | 17 | 113 | 2 | IPR004839 | |
| Domain | ATP_grasp_subdomain_1 | 5.21e-03 | 18 | 113 | 2 | IPR013815 | |
| Domain | - | 5.21e-03 | 18 | 113 | 2 | 3.30.470.20 | |
| Domain | PLAC | 5.80e-03 | 19 | 113 | 2 | PS50900 | |
| Domain | PLAC | 5.80e-03 | 19 | 113 | 2 | IPR010909 | |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.92e-17 | 42 | 98 | 12 | M48029 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 H2BC12 | 8.92e-16 | 68 | 98 | 13 | M27587 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 H2BC12 | 1.33e-15 | 70 | 98 | 13 | M48261 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.18e-15 | 55 | 98 | 12 | M29526 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 DNA2 H2BC12 | 2.61e-15 | 94 | 98 | 14 | M1080 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 H2BC12 | 3.46e-15 | 75 | 98 | 13 | M27343 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 DNA2 H2BC12 | 4.11e-15 | 97 | 98 | 14 | M27590 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 H2BC12 | 5.93e-15 | 78 | 98 | 13 | M27589 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.03e-14 | 62 | 98 | 12 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.55e-14 | 64 | 98 | 12 | M27429 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.30e-14 | 66 | 98 | 12 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.79e-14 | 67 | 98 | 12 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.79e-14 | 67 | 98 | 12 | M39003 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.37e-14 | 68 | 98 | 12 | M27658 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.86e-14 | 70 | 98 | 12 | M48028 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.94e-14 | 72 | 98 | 12 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.94e-14 | 72 | 98 | 12 | M27132 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.26e-14 | 73 | 98 | 12 | M27166 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.90e-13 | 78 | 98 | 12 | M1061 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.22e-13 | 79 | 98 | 12 | M27191 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 H2BC12 | 3.22e-13 | 105 | 98 | 13 | M27425 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 PHF20 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 HCFC1 | 5.46e-13 | 46 | 98 | 10 | MM14935 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 H2BC12 | 5.95e-13 | 110 | 98 | 13 | M27696 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 H2BC12 | 6.70e-13 | 111 | 98 | 13 | M27187 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 HLA-DRB1 GRIN2B H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.81e-13 | 139 | 98 | 14 | M4741 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 DNA2 H2BC12 | 7.52e-13 | 140 | 98 | 14 | M27584 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNA2 H2BC12 | 7.54e-13 | 112 | 98 | 13 | M4052 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 H2BC12 | 7.54e-13 | 112 | 98 | 13 | M48334 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.48e-13 | 88 | 98 | 12 | M1011 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 PHF20 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HCFC1 H2BC12 | 9.16e-13 | 142 | 98 | 14 | M27233 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.75e-13 | 89 | 98 | 12 | M27943 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.12e-12 | 90 | 98 | 12 | M2158 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.12e-12 | 90 | 98 | 12 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.12e-12 | 90 | 98 | 12 | M29668 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.28e-12 | 91 | 98 | 12 | M27101 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.67e-12 | 93 | 98 | 12 | M27487 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.91e-12 | 94 | 98 | 12 | M27230 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.46e-12 | 96 | 98 | 12 | M27792 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.80e-12 | 97 | 98 | 12 | M48262 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.52e-12 | 104 | 98 | 12 | M29829 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 7.82e-12 | 59 | 98 | 10 | M27763 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.21e-12 | 106 | 98 | 12 | M27458 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 DNA2 H2BC12 | 8.54e-12 | 167 | 98 | 14 | M19381 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.19e-12 | 107 | 98 | 12 | M48260 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.03e-11 | 108 | 98 | 12 | M27426 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 DNA2 H2BC12 | 1.09e-11 | 170 | 98 | 14 | M27582 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNA2 H2BC12 | 1.24e-11 | 139 | 98 | 13 | M868 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.28e-11 | 110 | 98 | 12 | M27958 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 H2BC12 | 1.63e-11 | 142 | 98 | 13 | M48257 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.42e-11 | 116 | 98 | 12 | M29806 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTSD H2BC12 | 3.01e-11 | 149 | 98 | 13 | M27888 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.29e-11 | 119 | 98 | 12 | M607 |
| Pathway | REACTOME_MEIOSIS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.63e-11 | 120 | 98 | 12 | M529 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.42e-11 | 122 | 98 | 12 | M29689 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.90e-11 | 125 | 98 | 12 | M27186 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.81e-11 | 128 | 98 | 12 | M48019 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.56e-11 | 129 | 98 | 12 | M27795 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | H2BC11 PHF20 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BUB1 H2BC5 H2BC3 HERC2 DNA2 H2BC12 | 1.49e-10 | 291 | 98 | 16 | M16647 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 1.60e-10 | 79 | 98 | 10 | M27742 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.89e-10 | 138 | 98 | 12 | M29805 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.06e-10 | 139 | 98 | 12 | M715 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC11 PHF20 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 HCFC1 H2BC12 | 2.18e-10 | 254 | 98 | 15 | M27131 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.64e-10 | 142 | 98 | 12 | M27660 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNA2 H2BC12 | 5.21e-10 | 187 | 98 | 13 | M1017 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 PHF20 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 HCFC1 H2BC12 | 5.68e-10 | 272 | 98 | 15 | M29619 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | SOX3 H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 LRP5 H2BC3 H2BC12 | 7.33e-10 | 233 | 98 | 14 | M27099 |
| Pathway | REACTOME_REPRODUCTION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.14e-10 | 158 | 98 | 12 | M26956 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.83e-10 | 159 | 98 | 12 | M27665 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 H2BC12 | 9.90e-10 | 197 | 98 | 13 | M27188 |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.22e-09 | 162 | 98 | 12 | M29804 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 3.80e-09 | 55 | 98 | 8 | MM14932 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTSD H2BC12 | 3.81e-09 | 220 | 98 | 13 | M27794 |
| Pathway | REACTOME_SIGNALING_BY_WNT | SOX3 H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 WNT16 H2BC5 LRP5 H2BC3 H2BC12 | 7.99e-09 | 330 | 98 | 15 | M7847 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTSD PCK1 H2BC12 | 1.60e-08 | 296 | 98 | 14 | M27869 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 3.16e-08 | 47 | 98 | 7 | MM15296 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 3.39e-08 | 72 | 98 | 8 | MM15381 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 PHF20 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 EHMT2 H2BC5 H2BC3 HCFC1 | 3.46e-08 | 175 | 98 | 11 | MM14941 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.06e-08 | 221 | 98 | 12 | M27578 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 4.70e-08 | 75 | 98 | 8 | MM15299 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 6.19e-08 | 31 | 98 | 6 | MM17225 | |
| Pathway | REACTOME_DNA_REPAIR | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 DNA2 H2BC12 | 6.73e-08 | 332 | 98 | 14 | M15434 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.75e-08 | 237 | 98 | 12 | M27786 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.26e-07 | 57 | 98 | 7 | MM15298 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.31e-07 | 246 | 98 | 12 | M10189 |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HCFC1 H2BC12 | 1.45e-07 | 299 | 98 | 13 | M27574 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 1.89e-07 | 37 | 98 | 6 | MM14883 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 2.23e-07 | 38 | 98 | 6 | MM15434 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 2.62e-07 | 39 | 98 | 6 | MM14850 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BUB1 H2BC5 H2BC3 H2BC12 | 3.52e-07 | 323 | 98 | 13 | M27080 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 5.51e-07 | 44 | 98 | 6 | MM15527 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 6.33e-07 | 45 | 98 | 6 | MM15508 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 7.77e-07 | 74 | 98 | 7 | MM14605 | |
| Pathway | REACTOME_M_PHASE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BUB1 H2BC5 H2BC3 PDS5A H2BC12 | 1.07e-06 | 417 | 98 | 14 | M27662 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.20e-06 | 50 | 98 | 6 | MM15308 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 1.40e-06 | 116 | 98 | 8 | MM15294 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 1.91e-06 | 54 | 98 | 6 | MM14904 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.37e-06 | 56 | 98 | 6 | MM17236 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 4.63e-06 | 136 | 98 | 8 | MM14848 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 4.77e-06 | 63 | 98 | 6 | MM15613 | |
| Pathway | REACTOME_CELL_CYCLE | H2BC11 PHF20 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BUB1 H2BC5 H2BC3 PDS5A HERC2 DNA2 H2BC12 | 5.23e-06 | 694 | 98 | 17 | M543 |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.65e-26 | 18 | 119 | 12 | 16283522 |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.65e-26 | 18 | 119 | 12 | 12757711 |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.14e-25 | 22 | 119 | 12 | 16713563 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.91e-24 | 23 | 119 | 12 | 16307923 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.19e-22 | 30 | 119 | 12 | 16319397 | |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 1.12e-18 | 17 | 119 | 9 | 16627869 |
| Pubmed | 2.42e-18 | 11 | 119 | 8 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 2.42e-18 | 11 | 119 | 8 | 16039583 | |
| Pubmed | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.44e-17 | 77 | 119 | 12 | 12408966 | |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 9.33e-17 | 15 | 119 | 8 | 17690254 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.24e-16 | 69 | 119 | 11 | 11689053 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.40e-15 | 73 | 119 | 11 | 14657027 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.40e-15 | 73 | 119 | 11 | 9566873 | |
| Pubmed | PRPF31 H2BC11 PCLO H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DDX39A H2BC12 | 2.19e-15 | 277 | 119 | 16 | 30745168 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.25e-15 | 86 | 119 | 11 | 11080476 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | EPRS1 H2BC11 CAD H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.40e-14 | 256 | 119 | 15 | 35777956 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 3.15e-14 | 67 | 119 | 10 | 25253489 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 H2BC18 H2BC13 H2BC15 TOX4 H2BC14 DDX46 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HCFC1 H2BC12 | 3.23e-14 | 271 | 119 | 15 | 32433965 |
| Pubmed | 2.63e-13 | 55 | 119 | 9 | 9439656 | ||
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC11 ABAT H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.81e-13 | 203 | 119 | 13 | 16916647 |
| Pubmed | TRPM6 PDXDC1 H2BC11 CAD H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 GLDC AMOT H2BC5 H2BC3 HCFC1 H2BC12 | 2.98e-13 | 451 | 119 | 17 | 36168627 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 5.14e-13 | 59 | 119 | 9 | 23254330 | |
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 2.58e-12 | 6 | 119 | 5 | 16457587 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPRS1 H2BC11 CAD H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 CTSD PCK2 H2BC12 | 9.01e-12 | 477 | 119 | 16 | 31300519 |
| Pubmed | EPRS1 H2BC11 CAD H2BC18 H2BC13 H2BC15 H2BC14 POLR3B H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.06e-11 | 425 | 119 | 15 | 21081503 | |
| Pubmed | PDXDC1 EPRS1 H2BC11 SPTLC2 H2BC18 H2BC12L BPNT2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 AMOT H2BC5 H2BC3 DDX39A PCK2 H2BC12 | 1.66e-10 | 878 | 119 | 19 | 37223481 | |
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 6.50e-10 | 5 | 119 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 6.50e-10 | 5 | 119 | 4 | 8620898 | |
| Pubmed | 8.42e-10 | 14 | 119 | 5 | 10064132 | ||
| Pubmed | PRPF31 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 H2BC3 | 2.59e-09 | 206 | 119 | 10 | 22174317 | |
| Pubmed | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 3.42e-09 | 212 | 119 | 10 | 23463506 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 3.56e-09 | 18 | 119 | 5 | 12860195 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.92e-09 | 438 | 119 | 13 | 21630459 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | H2BC11 CAD H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 H2BC12 | 4.22e-09 | 626 | 119 | 15 | 33644029 |
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 15019208 | ||
| Pubmed | H2BC11 CAD LYPLA2 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NOM1 CSTB H2BC5 H2BC3 H2BC12 | 4.84e-09 | 844 | 119 | 17 | 25963833 | |
| Pubmed | PRPF31 EPRS1 H2BC11 CAD H2BC18 H2BC13 H2BC15 H2BC14 DDX46 H2BC9 H2BC4 H2BC17 H2BC21 AMOT CSTB H2BC5 H2BC3 HCFC1 H2BC12 | 1.43e-08 | 1153 | 119 | 19 | 29845934 | |
| Pubmed | RPGRIP1 EPRS1 H2BC11 PCLO H2BC18 TNRC18 H2BC13 H2BC15 RIMKLB H2BC14 H2BC9 H2BC17 PXDN H2BC21 H2BC5 H2BC3 SPAG17 DDX39A PCK1 H2BC12 SLC17A6 | 1.93e-08 | 1442 | 119 | 21 | 35575683 | |
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 33097091 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PDXDC1 EPRS1 CAD SPTLC2 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 PPT1 AASS NOM1 H2BC5 DNA2 DDX39A HCFC1 GPAT4 H2BC12 | 5.58e-08 | 1257 | 119 | 19 | 37317656 |
| Pubmed | 1.95e-07 | 247 | 119 | 9 | 30713523 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 H2BC11 WNK1 H2BC13 H2BC15 H2BC14 POLR3B H2BC4 H2BC17 CSTB H2BC5 LRP5 H2BC3 DDX39A H2BC12 | 2.20e-07 | 847 | 119 | 15 | 35235311 |
| Pubmed | Retroposition of autosomal mRNA yielded testis-specific gene family on human Y chromosome. | 3.89e-07 | 5 | 119 | 3 | 10192397 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PRPF31 EPRS1 PHF20 MAP7D3 H2BC15 TOX4 H2BC14 DDX46 H2BC9 CELF1 EHMT2 NOM1 MITF H2BC5 PDS5A CDYL HCFC1 H2BC12 | 4.38e-07 | 1294 | 119 | 18 | 30804502 |
| Pubmed | PDXDC1 PRPF31 CAD MAP7D3 ERAP1 RAB11FIP1 WNK1 MET H2BC15 PXDN H2BC21 PPT1 CSTB PDS5A CDYL DDX39A CTSD HCFC1 | 4.53e-07 | 1297 | 119 | 18 | 33545068 | |
| Pubmed | 6.09e-07 | 88 | 119 | 6 | 26318153 | ||
| Pubmed | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. | 7.75e-07 | 6 | 119 | 3 | 22967069 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PRPF31 EPRS1 MAP7D3 H2BC18 H2BC12L H2BC13 H2BC15 TOX4 H2BC14 DDX46 H2BC9 H2BC5 PDS5A HCFC1 H2BC12 | 9.78e-07 | 954 | 119 | 15 | 36373674 |
| Pubmed | 1.31e-06 | 24 | 119 | 4 | 27754788 | ||
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 1.35e-06 | 7 | 119 | 3 | 8858345 | |
| Pubmed | The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. | 1.35e-06 | 7 | 119 | 3 | 23240083 | |
| Pubmed | Mammalian chromodomain proteins: their role in genome organisation and expression. | 2.16e-06 | 8 | 119 | 3 | 10655032 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 9710638 | ||
| Pubmed | Previously uncharacterized histone acetyltransferases implicated in mammalian spermatogenesis. | 2.16e-06 | 8 | 119 | 3 | 12072557 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDXDC1 CAD MAP7D3 PCLO TMCC3 DIP2A EHMT2 AASS NOM1 BUB1 GHITM H2BC5 H2BC3 ALAS1 HERC2 GPAT4 PCK2 ALG13 | 3.42e-06 | 1496 | 119 | 18 | 32877691 |
| Pubmed | 4.09e-06 | 267 | 119 | 8 | 33417871 | ||
| Pubmed | CAD HLA-DRB1 AKR1A1 GGT1 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC5 | 4.09e-06 | 565 | 119 | 11 | 20458337 | |
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 6.28e-06 | 35 | 119 | 4 | 9119399 | |
| Pubmed | EPRS1 CAD LYPLA2 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC5 | 7.74e-06 | 491 | 119 | 10 | 22623428 | |
| Pubmed | TRPM6 ADAM19 CAMK1D CAMK1G WNK1 GALNT13 GGT1 KIF3A POLR3B EHMT2 HECW2 HCFC1 | 8.18e-06 | 730 | 119 | 12 | 34857952 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PRPF31 MAP7D3 KIF1B STIL RAB11FIP1 WNK1 TMCC3 H2BC13 AASS AMOT SIK2 FAM53B RAPGEF2 | 8.38e-06 | 861 | 119 | 13 | 36931259 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 9.06e-06 | 394 | 119 | 9 | 27248496 | |
| Pubmed | MED20 H2BC11 HLA-DRB1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 MED23 H2BC12 | 1.01e-05 | 622 | 119 | 11 | 14574404 | |
| Pubmed | 1.09e-05 | 13 | 119 | 3 | 8858344 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18393273 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23629948 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22234890 | ||
| Pubmed | Antigenic peptide trimming by ER aminopeptidases--insights from structural studies. | 1.16e-05 | 2 | 119 | 2 | 23545452 | |
| Pubmed | Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis. | 1.16e-05 | 2 | 119 | 2 | 38697449 | |
| Pubmed | Use of model organisms for the study of neuronal ceroid lipofuscinosis. | 1.16e-05 | 2 | 119 | 2 | 23338040 | |
| Pubmed | c-Met expression is regulated by Mitf in the melanocyte lineage. | 1.16e-05 | 2 | 119 | 2 | 16455654 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32321463 | ||
| Pubmed | Functionally distinct ERAP1 and ERAP2 are a hallmark of HLA-A29-(Birdshot) Uveitis. | 1.16e-05 | 2 | 119 | 2 | 30215709 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16132948 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12436110 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12436109 | ||
| Pubmed | ERAP1-ERAP2 haplotypes are associated with ankylosing spondylitis in Polish patients. | 1.16e-05 | 2 | 119 | 2 | 30794838 | |
| Pubmed | Differential expression of molecular motors in the motor cortex of sporadic ALS. | 1.16e-05 | 2 | 119 | 2 | 17418584 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20843824 | ||
| Pubmed | CUG-BP1 regulates RyR1 ASI alternative splicing in skeletal muscle atrophy. | 1.16e-05 | 2 | 119 | 2 | 26531141 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33138063 | ||
| Pubmed | ERAP1-ERAP2 dimerization increases peptide-trimming efficiency. | 1.16e-05 | 2 | 119 | 2 | 24928998 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20419298 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16585582 | ||
| Pubmed | Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. | 1.16e-05 | 2 | 119 | 2 | 19433412 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22106953 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15908954 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33309189 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29108111 | ||
| Pubmed | Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis. | 1.16e-05 | 2 | 119 | 2 | 34020084 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29183862 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29991817 | ||
| Pubmed | MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor. | 1.16e-05 | 2 | 119 | 2 | 36139568 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28063628 | ||
| Pubmed | The ERAP gene is associated with HCV chronic infection in a Chinese Han population. | 1.16e-05 | 2 | 119 | 2 | 29037997 | |
| Pubmed | PEPCK-M expression in mouse liver potentiates, not replaces, PEPCK-C mediated gluconeogenesis. | 1.16e-05 | 2 | 119 | 2 | 23466304 | |
| Pubmed | Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. | 1.16e-05 | 2 | 119 | 2 | 3261170 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28109345 | ||
| Pubmed | GluN2B in corticostriatal circuits governs choice learning and choice shifting. | 1.16e-05 | 2 | 119 | 2 | 23831965 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8611618 | ||
| Interaction | CDK5R2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.99e-19 | 23 | 117 | 11 | int:CDK5R2 |
| Interaction | TNN interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.99e-19 | 23 | 117 | 11 | int:TNN |
| Interaction | CYLC1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.17e-18 | 20 | 117 | 10 | int:CYLC1 |
| Interaction | DUOX2 interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.77e-18 | 30 | 117 | 11 | int:DUOX2 |
| Interaction | HMGN3 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.10e-15 | 64 | 117 | 12 | int:HMGN3 |
| Interaction | HMGN2 interactions | EPRS1 H2BC11 MXRA5 PCLO WNK1 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AMOT H2BC5 H2BC3 H2BC12 | 1.26e-14 | 222 | 117 | 17 | int:HMGN2 |
| Interaction | DPPA2 interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.15e-14 | 40 | 117 | 10 | int:DPPA2 |
| Interaction | TEX35 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.30e-14 | 57 | 117 | 11 | int:TEX35 |
| Interaction | H2BC26 interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 CDYL H2BC12 | 1.86e-13 | 183 | 117 | 15 | int:H2BC26 |
| Interaction | HCLS1 interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.99e-13 | 71 | 117 | 11 | int:HCLS1 |
| Interaction | FAM47B interactions | 3.09e-13 | 13 | 117 | 7 | int:FAM47B | |
| Interaction | LOC102724334 interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.45e-13 | 134 | 117 | 13 | int:LOC102724334 |
| Interaction | H2AC7 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.29e-12 | 107 | 117 | 12 | int:H2AC7 |
| Interaction | H2BC13 interactions | EPRS1 H2BC11 PCLO H2BC18 TNRC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.39e-12 | 210 | 117 | 15 | int:H2BC13 |
| Interaction | H2BC17 interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.67e-12 | 140 | 117 | 13 | int:H2BC17 |
| Interaction | H2AC25 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.03e-12 | 84 | 117 | 11 | int:H2AC25 |
| Interaction | H2BC1 interactions | EPRS1 H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 CDYL H2BC12 | 2.19e-12 | 178 | 117 | 14 | int:H2BC1 |
| Interaction | H2BC15 interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.40e-12 | 144 | 117 | 13 | int:H2BC15 |
| Interaction | H2BC18 interactions | PRPF31 H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.55e-12 | 180 | 117 | 14 | int:H2BC18 |
| Interaction | ZNF474 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 3.28e-12 | 44 | 117 | 9 | int:ZNF474 |
| Interaction | H2AC18 interactions | EPRS1 H2BC11 H2BC18 TNRC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.41e-12 | 148 | 117 | 13 | int:H2AC18 |
| Interaction | PCLO interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 8.71e-12 | 70 | 117 | 10 | int:PCLO |
| Interaction | H2BC14 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.44e-11 | 100 | 117 | 11 | int:H2BC14 |
| Interaction | HMGN4 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.44e-11 | 100 | 117 | 11 | int:HMGN4 |
| Interaction | PSMD14 interactions | PRPF31 H2BC11 PCLO H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 MITF H2BC5 H2BC3 HERC2 DDX39A PCK1 H2BC12 | 2.53e-11 | 527 | 117 | 20 | int:PSMD14 |
| Interaction | H2BC12 interactions | EPRS1 H2BC11 PCLO H2BC18 TNRC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 SPAG17 H2BC12 | 5.84e-11 | 322 | 117 | 16 | int:H2BC12 |
| Interaction | H2BC11 interactions | H2BC11 PCLO H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.20e-11 | 186 | 117 | 13 | int:H2BC11 |
| Interaction | JPH2 interactions | 8.17e-11 | 25 | 117 | 7 | int:JPH2 | |
| Interaction | H2AC6 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.29e-10 | 100 | 117 | 10 | int:H2AC6 |
| Interaction | H2BC4 interactions | EPRS1 H2BC11 H2BC18 TNRC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 SPAG17 H2BC12 | 3.34e-10 | 259 | 117 | 14 | int:H2BC4 |
| Interaction | H2AC13 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.00e-10 | 75 | 117 | 9 | int:H2AC13 |
| Interaction | PDS5B interactions | PRPF31 H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 PDS5A H2BC12 | 5.32e-10 | 178 | 117 | 12 | int:PDS5B |
| Interaction | SFMBT2 interactions | 5.53e-10 | 32 | 117 | 7 | int:SFMBT2 | |
| Interaction | H2BC5 interactions | EPRS1 H2BC11 PCLO H2BC18 TNRC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.67e-10 | 331 | 117 | 15 | int:H2BC5 |
| Interaction | H2AC12 interactions | H2BC11 H2BC18 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.70e-09 | 118 | 117 | 10 | int:H2AC12 |
| Interaction | H2BC3 interactions | PRPF31 EPRS1 H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CELF1 H2BC5 H2BC3 PDS5A H2BC12 | 1.73e-09 | 406 | 117 | 16 | int:H2BC3 |
| Interaction | H2AC11 interactions | EPRS1 H2BC11 H2BC18 TNRC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.16e-09 | 248 | 117 | 13 | int:H2AC11 |
| Interaction | ARHGAP24 interactions | TRPM6 PDXDC1 H2BC11 CAD H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 GLDC AMOT H2BC5 H2BC3 HCFC1 H2BC12 | 3.11e-09 | 486 | 117 | 17 | int:ARHGAP24 |
| Interaction | H2AJ interactions | H2BC11 H2BC18 H2BC13 H2BC15 DDX46 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.48e-09 | 127 | 117 | 10 | int:H2AJ |
| Interaction | H2BC9 interactions | EPRS1 H2BC11 PCLO H2BC18 TNRC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 SPAG17 H2BC12 | 6.59e-09 | 446 | 117 | 16 | int:H2BC9 |
| Interaction | H2AC1 interactions | 7.95e-09 | 71 | 117 | 8 | int:H2AC1 | |
| Interaction | H2AC14 interactions | H2BC11 H2BC18 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.18e-08 | 144 | 117 | 10 | int:H2AC14 |
| Interaction | RIOK1 interactions | MED20 EPRS1 H2BC11 CAD H2BC18 H2BC13 H2BC15 H2BC14 POLR3B H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 MED23 H2BC12 | 2.65e-08 | 562 | 117 | 17 | int:RIOK1 |
| Interaction | H3-4 interactions | EPRS1 H2BC11 ERAP1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 EHMT2 H2BC5 CDYL HERC2 RAPGEF2 H2BC12 | 5.04e-08 | 448 | 117 | 15 | int:H3-4 |
| Interaction | H2AX interactions | H2BC11 H2BC18 TNRC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 CDYL CTSD HCFC1 H2BC12 | 5.78e-08 | 593 | 117 | 17 | int:H2AX |
| Interaction | ELK4 interactions | 6.28e-08 | 92 | 117 | 8 | int:ELK4 | |
| Interaction | TMEM196 interactions | 7.42e-08 | 8 | 117 | 4 | int:TMEM196 | |
| Interaction | MAP1B interactions | EPRS1 H2BC11 CAD H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPT1 H2BC5 H2BC3 H2BC12 | 9.16e-08 | 539 | 117 | 16 | int:MAP1B |
| Interaction | H2BC21 interactions | EPRS1 H2BC11 PCLO H2BC18 H2BC13 H2BC15 TOX4 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 CDYL HCFC1 H2BC12 | 1.07e-07 | 696 | 117 | 18 | int:H2BC21 |
| Interaction | IPO9 interactions | RPGRIP1 EPRS1 H2BC18 H2BC13 H2BC14 POLR3B H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 1.31e-07 | 236 | 117 | 11 | int:IPO9 |
| Interaction | IGSF8 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 GHITM H2BC5 H2BC3 H2BC12 | 1.49e-07 | 239 | 117 | 11 | int:IGSF8 |
| Interaction | HMGA1 interactions | H2BC11 PCLO H2BC18 TNRC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 HCFC1 H2BC12 | 1.49e-07 | 419 | 117 | 14 | int:HMGA1 |
| Interaction | MAPK7 interactions | 1.53e-07 | 143 | 117 | 9 | int:MAPK7 | |
| Interaction | MCM5 interactions | H2BC11 RAB11FIP1 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.54e-07 | 420 | 117 | 14 | int:MCM5 |
| Interaction | ADARB1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 TOX4 H2BC14 DDX46 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HCFC1 H2BC12 | 1.57e-07 | 489 | 117 | 15 | int:ADARB1 |
| Interaction | TTN interactions | RYR1 H2BC18 TNRC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 AMOT H2BC5 RAPGEF2 H2BC12 | 1.75e-07 | 299 | 117 | 12 | int:TTN |
| Interaction | CEP350 interactions | 2.17e-07 | 149 | 117 | 9 | int:CEP350 | |
| Interaction | H2AC4 interactions | EPRS1 H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CDYL HCFC1 H2BC12 | 2.43e-07 | 506 | 117 | 15 | int:H2AC4 |
| Interaction | UBA52 interactions | EPRS1 H2BC11 H2BC18 TNRC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.49e-07 | 437 | 117 | 14 | int:UBA52 |
| Interaction | H2AZ1 interactions | H2BC11 H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 H2BC5 H2BC3 CDYL HCFC1 H2BC12 | 2.49e-07 | 371 | 117 | 13 | int:H2AZ1 |
| Interaction | DOK2 interactions | 3.82e-07 | 116 | 117 | 8 | int:DOK2 | |
| Interaction | RPS27A interactions | EPRS1 H2BC11 H2BC18 TNRC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 GLDC H2BC5 H2BC3 H2BC12 | 5.06e-07 | 536 | 117 | 15 | int:RPS27A |
| Interaction | ADAMTS12 interactions | 7.74e-07 | 55 | 117 | 6 | int:ADAMTS12 | |
| Interaction | IFT74 interactions | 1.09e-06 | 133 | 117 | 8 | int:IFT74 | |
| Interaction | CD81 interactions | H2BC11 GGT1 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 1.56e-06 | 303 | 117 | 11 | int:CD81 |
| Interaction | ADAMTS19 interactions | 1.89e-06 | 5 | 117 | 3 | int:ADAMTS19 | |
| Interaction | PINK1 interactions | EPRS1 H2BC11 CAD H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 CTSD PCK2 H2BC12 | 1.97e-06 | 679 | 117 | 16 | int:PINK1 |
| Interaction | ICAM1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 2.16e-06 | 252 | 117 | 10 | int:ICAM1 |
| Interaction | PRKCB interactions | H2BC11 GRIN2B H2BC13 H2BC15 H2BC14 DDX46 H2BC21 H2BC5 H2BC3 H2BC12 | 2.40e-06 | 255 | 117 | 10 | int:PRKCB |
| Interaction | H4C9 interactions | 3.19e-06 | 108 | 117 | 7 | int:H4C9 | |
| Interaction | MAP7D2 interactions | 3.26e-06 | 70 | 117 | 6 | int:MAP7D2 | |
| Interaction | H3C15 interactions | 3.39e-06 | 207 | 117 | 9 | int:H3C15 | |
| Interaction | H3C1 interactions | EPRS1 H2BC11 PHF20 H2BC18 TNRC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EHMT2 CSTB H2BC5 H2BC3 PDS5A CDYL H2BC12 | 4.39e-06 | 901 | 117 | 18 | int:H3C1 |
| Interaction | H3-5 interactions | 4.57e-06 | 114 | 117 | 7 | int:H3-5 | |
| Interaction | SPAG17 interactions | 4.87e-06 | 20 | 117 | 4 | int:SPAG17 | |
| Interaction | USF3 interactions | 4.87e-06 | 20 | 117 | 4 | int:USF3 | |
| Interaction | HEXIM1 interactions | EPRS1 H2BC11 CAD H2BC18 H2BC13 H2BC15 TOX4 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AMOT CSTB H2BC5 H2BC3 HCFC1 H2BC12 | 5.27e-06 | 913 | 117 | 18 | int:HEXIM1 |
| Interaction | TMA7 interactions | 6.86e-06 | 46 | 117 | 5 | int:TMA7 | |
| Interaction | PDCD4 interactions | 8.76e-06 | 176 | 117 | 8 | int:PDCD4 | |
| Interaction | MEPCE interactions | PRPF31 EPRS1 H2BC11 CAD H2BC18 H2BC13 H2BC15 TOX4 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 GLDC H2BC5 H2BC3 H2BC12 | 9.43e-06 | 859 | 117 | 17 | int:MEPCE |
| Interaction | PDZD7 interactions | 1.05e-05 | 8 | 117 | 3 | int:PDZD7 | |
| Interaction | CDYL interactions | 1.24e-05 | 88 | 117 | 6 | int:CDYL | |
| Interaction | ENY2 interactions | 1.31e-05 | 186 | 117 | 8 | int:ENY2 | |
| Interaction | BTF3 interactions | H2BC11 CAD STIL H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HERC2 H2BC12 | 1.53e-05 | 799 | 117 | 16 | int:BTF3 |
| Interaction | MYO1H interactions | 1.56e-05 | 9 | 117 | 3 | int:MYO1H | |
| Interaction | KBTBD4 interactions | PRPF31 H2BC11 MAP7D3 WNK1 TOX4 H2BC17 H2BC21 H2BC3 DDX39A HCFC1 | 1.58e-05 | 316 | 117 | 10 | int:KBTBD4 |
| Interaction | TNRC18 interactions | 1.60e-05 | 92 | 117 | 6 | int:TNRC18 | |
| Interaction | H2AC20 interactions | H2BC11 H2BC18 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 CDYL H2BC12 | 1.76e-05 | 320 | 117 | 10 | int:H2AC20 |
| Interaction | UBB interactions | MED20 H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.77e-05 | 467 | 117 | 12 | int:UBB |
| Interaction | OSBPL9 interactions | 2.04e-05 | 96 | 117 | 6 | int:OSBPL9 | |
| Interaction | LARP7 interactions | PRPF31 EPRS1 H2BC11 CAD H2BC18 H2BC13 H2BC15 H2BC14 DDX46 H2BC9 H2BC4 H2BC17 H2BC21 GLDC AMOT CSTB H2BC5 H2BC3 H2BC12 | 2.16e-05 | 1113 | 117 | 19 | int:LARP7 |
| Interaction | SSB interactions | PRPF31 EPRS1 TNRC18 H2BC13 H2BC9 H2BC4 H2BC21 PPT1 H2BC5 H2BC3 HERC2 H2BC12 | 2.51e-05 | 484 | 117 | 12 | int:SSB |
| Interaction | ESCO1 interactions | 2.63e-05 | 30 | 117 | 4 | int:ESCO1 | |
| Interaction | KNOP1 interactions | 3.02e-05 | 272 | 117 | 9 | int:KNOP1 | |
| Interaction | SPON2 interactions | 3.04e-05 | 11 | 117 | 3 | int:SPON2 | |
| Interaction | TOMM70 interactions | 3.13e-05 | 153 | 117 | 7 | int:TOMM70 | |
| Interaction | SPRTN interactions | CAD H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 PPT1 NOM1 H2BC5 H2BC3 DDX39A H2BC12 | 4.31e-05 | 596 | 117 | 13 | int:SPRTN |
| Interaction | SECISBP2L interactions | 4.37e-05 | 34 | 117 | 4 | int:SECISBP2L | |
| Interaction | H4C7 interactions | 4.92e-05 | 35 | 117 | 4 | int:H4C7 | |
| Interaction | MAGIX interactions | 4.92e-05 | 35 | 117 | 4 | int:MAGIX | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 6.61e-08 | 378 | 120 | 10 | chr6p22 |
| Cytoband | 6p22.1 | 2.15e-06 | 142 | 120 | 6 | 6p22.1 | |
| Cytoband | Xq23 | 3.51e-04 | 52 | 120 | 3 | Xq23 | |
| Cytoband | 6p21.3 | 5.27e-04 | 250 | 120 | 5 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq23 | 1.68e-03 | 89 | 120 | 3 | chrXq23 | |
| Cytoband | 7q31 | 2.28e-03 | 27 | 120 | 2 | 7q31 | |
| Cytoband | 1p32 | 2.28e-03 | 27 | 120 | 2 | 1p32 | |
| GeneFamily | Histones | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.44e-15 | 116 | 78 | 13 | 864 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.70e-05 | 36 | 78 | 4 | 823 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | H2BC11 CWH43 ERAP1 BBS10 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 CELF1 ERAP2 H2BC5 H2BC3 IFI44L H2BC12 ALG13 | 1.38e-08 | 768 | 120 | 18 | M6444 |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 2.87e-06 | 22 | 120 | 4 | M7362 | |
| Coexpression | EGFR_UP.V1_DN | 3.48e-06 | 196 | 120 | 8 | M2633 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 3.75e-06 | 198 | 120 | 8 | MM17083 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 4.04e-06 | 200 | 120 | 8 | M9952 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | H2BC11 ERAP1 STIL H2BC18 H2BC13 H2BC15 RIMKLB H2BC14 H2BC9 H2BC4 PPT1 ERAP2 BUB1 H2BC3 DNA2 PCK2 | 6.16e-06 | 939 | 120 | 16 | M45768 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.24e-05 | 111 | 120 | 6 | MM705 | |
| Coexpression | ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN | 1.36e-05 | 32 | 120 | 4 | M40951 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | H2BC11 CAMK1D ERAP1 AQP11 GGT1 H2BC18 KIF3A H2BC13 POLR3B H2BC4 H2BC17 PPT1 OR2Y1 CSTB H2BC5 CREB3L3 H2BC12 SLC17A6 | 1.37e-05 | 1239 | 120 | 18 | M1743 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | H2BC11 CAD CAMK1D LYPLA2 AQP11 POLR3B H2BC9 H2BC17 PPT1 ANGPTL4 CSTB DDX39A CTSD GPAT4 H2BC12 SLC17A6 | 1.80e-05 | 1024 | 120 | 16 | M1742 |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 3.77e-05 | 199 | 120 | 7 | M3460 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 3.77e-05 | 199 | 120 | 7 | M9954 | |
| Coexpression | GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN | 3.77e-05 | 199 | 120 | 7 | M3107 | |
| Coexpression | GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 3.90e-05 | 200 | 120 | 7 | M9474 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN | 3.90e-05 | 200 | 120 | 7 | M8612 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 3.90e-05 | 200 | 120 | 7 | M5247 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | 5.11e-05 | 368 | 120 | 9 | M16431 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | 5.32e-05 | 461 | 120 | 10 | M14127 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL | H2BC11 PKHD1L1 H2BC18 H2BC15 RIMKLB H2BC4 H2BC21 MITF H2BC12 | 7.09e-05 | 384 | 120 | 9 | M45735 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 8.11e-05 | 96 | 120 | 5 | M1683 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN | 8.84e-05 | 51 | 120 | 4 | M2218 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | CAD CAMK1D LYPLA2 AQP11 H2BC13 H2BC14 POLR3B H2BC9 PPT1 ANGPTL4 CSTB DDX39A CTSD GPAT4 SLC17A6 | 1.16e-04 | 1072 | 120 | 15 | MM1031 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 1.55e-04 | 426 | 120 | 9 | M9516 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 1.79e-04 | 179 | 120 | 6 | M16932 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 1.95e-04 | 259 | 120 | 7 | M40029 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 2.14e-04 | 118 | 120 | 5 | M15305 | |
| Coexpression | PATIL_LIVER_CANCER | RAB11FIP1 WNK1 BPNT2 H2BC4 H2BC21 EHMT2 BUB1 AACS H2BC5 HCFC1 H2BC12 | 2.30e-04 | 660 | 120 | 11 | M1195 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 2.33e-04 | 450 | 120 | 9 | M45747 | |
| Coexpression | E2F1_UP.V1_UP | 2.33e-04 | 188 | 120 | 6 | M2632 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_DN | 2.35e-04 | 267 | 120 | 7 | M13449 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | H2BC11 CAMK1D ERAP1 AQP11 GGT1 H2BC18 KIF3A H2BC13 H2BC14 POLR3B PPT1 OR2Y1 CSTB H2BC5 CREB3L3 SLC17A6 | 2.40e-04 | 1277 | 120 | 16 | MM1032 |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 2.69e-04 | 193 | 120 | 6 | M3484 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP | 3.00e-04 | 197 | 120 | 6 | M5217 | |
| Coexpression | GLINSKY_CANCER_DEATH_UP | 3.08e-04 | 6 | 120 | 2 | MM1267 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN | 3.08e-04 | 198 | 120 | 6 | M3352 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 3.08e-04 | 198 | 120 | 6 | M6114 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 3.08e-04 | 198 | 120 | 6 | M7948 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN | 3.17e-04 | 199 | 120 | 6 | M7667 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 3.17e-04 | 199 | 120 | 6 | M5230 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP | 3.17e-04 | 199 | 120 | 6 | M7845 | |
| Coexpression | GSE5960_TH1_VS_ANERGIC_TH1_UP | 3.17e-04 | 199 | 120 | 6 | M5637 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 3.25e-04 | 200 | 120 | 6 | M107 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN | 3.25e-04 | 200 | 120 | 6 | M4593 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP | 3.25e-04 | 200 | 120 | 6 | M6398 | |
| Coexpression | GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN | 3.25e-04 | 200 | 120 | 6 | M5139 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN | 3.25e-04 | 200 | 120 | 6 | M5019 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 3.34e-04 | 283 | 120 | 7 | M39117 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 3.47e-04 | 30 | 120 | 3 | M47990 | |
| Coexpression | YAGI_AML_WITH_T_9_11_TRANSLOCATION | 3.48e-04 | 131 | 120 | 5 | M16922 | |
| Coexpression | DANG_BOUND_BY_MYC | H2BC11 CAD SPTLC2 AKR1A1 H2BC12L MET H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BUB1 CSTB | 3.60e-04 | 1061 | 120 | 14 | M15774 |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 1.88e-08 | 32 | 116 | 6 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 1.09e-07 | 70 | 116 | 7 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 1.60e-07 | 110 | 116 | 8 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | H2BC11 RAB11FIP1 H2BC13 H2BC15 H2BC14 H2BC17 GLDC MARVELD3 H2BC12 | 2.04e-07 | 157 | 116 | 9 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | H2BC11 GGT1 H2BC13 H2BC15 H2BC14 H2BC17 ADAMTS18 H2BC5 H2BC12 | 2.66e-07 | 162 | 116 | 9 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 3.05e-07 | 50 | 116 | 6 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | 4.30e-07 | 125 | 116 | 8 | facebase_RNAseq_e9.5_MandArch_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | H2BC11 RGS9 RAB11FIP1 H2BC13 H2BC15 H2BC14 H2BC17 GLDC ADAMTS18 H2BC5 MARVELD3 H2BC12 | 2.10e-06 | 402 | 116 | 12 | facebase_RNAseq_e10.5_OlfacPit_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 2.72e-06 | 72 | 116 | 6 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K4 | H2BC11 RGS9 RAB11FIP1 GGT1 MET H2BC13 H2BC15 H2BC17 GLDC ADAMTS18 MARVELD3 H2BC12 | 4.30e-06 | 431 | 116 | 12 | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 1.14e-05 | 54 | 116 | 5 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 1.62e-05 | 58 | 116 | 5 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500 | H2BC11 AQP11 RGS9 STIL RAB11FIP1 TMCC3 H2BC18 NRP2 H2BC13 H2BC15 RIMKLB H2BC14 H2BC17 GLDC AMOT BUB1 ADAMTS18 H2BC5 H2BC3 MARVELD3 H2BC12 | 3.62e-05 | 1453 | 116 | 21 | facebase_RNAseq_e10.5_OlfacPit_2500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.90e-05 | 123 | 116 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 8.85e-05 | 43 | 116 | 4 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3 | 1.03e-04 | 339 | 116 | 9 | GSM777027_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 1.87e-04 | 52 | 116 | 4 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 2.16e-04 | 374 | 116 | 9 | GSM538389_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.46e-04 | 300 | 116 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | H2BC11 AQP11 RAB11FIP1 H2BC18 NRP2 BPNT2 H2BC13 H2BC15 RIMKLB H2BC14 H2BC17 GLDC BUB1 H2BC5 H2BC3 CDYL H2BC12 | 2.83e-04 | 1202 | 116 | 17 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 3.35e-04 | 25 | 116 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 3.46e-04 | 110 | 116 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | 3.66e-04 | 402 | 116 | 9 | GSM791105_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 4.15e-04 | 409 | 116 | 9 | GSM538234_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3 | 4.45e-04 | 413 | 116 | 9 | GSM791149_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 4.86e-04 | 418 | 116 | 9 | GSM538350_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_CollectIng Duct_2500_K2 | H2BC11 RAB11FIP1 GGT1 MET H2BC13 H2BC15 H2BC17 GLDC ADAMTS18 MARVELD3 H2BC12 | 5.10e-04 | 609 | 116 | 11 | gudmap_RNAseq_e15.5_CollectIng Duct_2500_K2 |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2 | 5.20e-04 | 422 | 116 | 9 | GSM791124_500 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220+.BM, CD138+ AA4.1+ CD43- CD45R+, Bone marrow, avg-3 | 5.33e-04 | 337 | 116 | 8 | GSM777024_500 | |
| CoexpressionAtlas | B cells, MLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-3 | 5.47e-04 | 425 | 116 | 9 | GSM791131_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.20e-04 | 71 | 116 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.24e-09 | 196 | 120 | 9 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 1.42e-08 | 162 | 120 | 8 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 5.53e-08 | 193 | 120 | 8 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-07 | 174 | 120 | 7 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-07 | 174 | 120 | 7 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.10e-07 | 176 | 120 | 7 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-07 | 179 | 120 | 7 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-07 | 179 | 120 | 7 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 182 | 120 | 7 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-07 | 187 | 120 | 7 | b7689e7f6511920cd2beff27389555fddf685f61 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 195 | 120 | 7 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 195 | 120 | 7 | 3f517c6fc372bdcaf45b3af373414f13cbebd4ba | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 195 | 120 | 7 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 1.09e-06 | 197 | 120 | 7 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 199 | 120 | 7 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.20e-06 | 200 | 120 | 7 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.95e-06 | 147 | 120 | 6 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.48e-06 | 158 | 120 | 6 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, Lineage and Cell Type | 4.48e-06 | 158 | 120 | 6 | 05a29c2d5506a25ccdfa4c6a86e9188977a18272 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.99e-06 | 161 | 120 | 6 | 0e2b54a63781397f6b99eb0e201fbb820cbd7cc6 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-06 | 168 | 120 | 6 | b9db0b1e4fe54a1fe79530d15d206155a1bfac39 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-06 | 170 | 120 | 6 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-06 | 171 | 120 | 6 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-06 | 172 | 120 | 6 | a5344760b10ecdc0101f78b93b8fc0f8107068c5 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 8.86e-06 | 178 | 120 | 6 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.44e-06 | 180 | 120 | 6 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.44e-06 | 180 | 120 | 6 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-06 | 180 | 120 | 6 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-06 | 181 | 120 | 6 | bec7076efe94898213a62db72d171d737949977e | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-06 | 181 | 120 | 6 | cf149b30b814cf87c9e923ef502cadf7fe4a3597 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 182 | 120 | 6 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 182 | 120 | 6 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 182 | 120 | 6 | 3948422707d6d5e021bcd7158e2eb69143613f62 | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 1.01e-05 | 182 | 120 | 6 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 182 | 120 | 6 | fe46819c153a81911864473badc794f243705f98 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 182 | 120 | 6 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 184 | 120 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 184 | 120 | 6 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 184 | 120 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 184 | 120 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | lymphoid-T_cell-CD8+_Effector_T_cell|T_cell / Lineage, cell class and subclass | 1.07e-05 | 184 | 120 | 6 | f610f28f8319d194871a3e94210bf1c493918986 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 120 | 6 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 187 | 120 | 6 | 60c2576f31a60f819deb9ec500d1f714b469df4e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-05 | 188 | 120 | 6 | 3f47395db7e6159fc95810545bad4b6e028464c5 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 1.21e-05 | 188 | 120 | 6 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 188 | 120 | 6 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 188 | 120 | 6 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-05 | 189 | 120 | 6 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 189 | 120 | 6 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-05 | 189 | 120 | 6 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 1.28e-05 | 190 | 120 | 6 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 1.32e-05 | 191 | 120 | 6 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.36e-05 | 192 | 120 | 6 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 193 | 120 | 6 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 193 | 120 | 6 | db881cc129b45031fd84d052768cef53508de196 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.49e-05 | 195 | 120 | 6 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 195 | 120 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 195 | 120 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.49e-05 | 195 | 120 | 6 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 195 | 120 | 6 | e94bac6a5c788ee160d7feaf2a3c512a3691f995 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-05 | 196 | 120 | 6 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-05 | 196 | 120 | 6 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.53e-05 | 196 | 120 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-05 | 197 | 120 | 6 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.58e-05 | 197 | 120 | 6 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.58e-05 | 197 | 120 | 6 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.58e-05 | 197 | 120 | 6 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.58e-05 | 197 | 120 | 6 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.58e-05 | 197 | 120 | 6 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 1.58e-05 | 197 | 120 | 6 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.58e-05 | 197 | 120 | 6 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.58e-05 | 197 | 120 | 6 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | Caecum-B_cell-B_cell_cycling|Caecum / Region, Cell class and subclass | 1.62e-05 | 198 | 120 | 6 | 61294fe99a5641ad359796022c3d038470076b3c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 198 | 120 | 6 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | C_01|World / shred on cell type and cluster | 1.62e-05 | 198 | 120 | 6 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 120 | 6 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 198 | 120 | 6 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 1.62e-05 | 198 | 120 | 6 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 120 | 6 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 120 | 6 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Caecum-(2)_B_cell-(24)_B_cell_cycling|Caecum / shred on region, Cell_type, and subtype | 1.62e-05 | 198 | 120 | 6 | 568d47770cd20c6569ca84ea1eafde367642d68b | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 120 | 6 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-05 | 198 | 120 | 6 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, condition lineage and cell class | 1.67e-05 | 199 | 120 | 6 | 1b17e6d5e6b994dec65efae2667f4f1f438161b1 | |
| ToppCell | NS-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-05 | 200 | 120 | 6 | d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-05 | 200 | 120 | 6 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-05 | 200 | 120 | 6 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | e1b3fc516887510b18cf688ada0e00b5f5eff684 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 1.72e-05 | 200 | 120 | 6 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-05 | 137 | 120 | 5 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.62e-05 | 138 | 120 | 5 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.50e-05 | 156 | 120 | 5 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.50e-05 | 156 | 120 | 5 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 159 | 120 | 5 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-05 | 160 | 120 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Platelet|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.32e-05 | 160 | 120 | 5 | 768f3cefc3ad4cda229e598cce8bde574cf64bb2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-05 | 160 | 120 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-05 | 161 | 120 | 5 | 5cb91ae9674b370a27be0d5852c3816b4434239e | |
| ToppCell | IIF-Lymphocyte-B-Plasmablast|IIF / Disease, Lineage and Cell Type | 7.54e-05 | 161 | 120 | 5 | 4d78985e7b11e92591e75a4864fd769882db2d1c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.54e-05 | 161 | 120 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| Computational | Genes in the cancer module 89. | 1.86e-06 | 14 | 73 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 3.35e-06 | 16 | 73 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 4.36e-06 | 17 | 73 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 5.57e-06 | 18 | 73 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 534. | 5.57e-06 | 18 | 73 | 4 | MODULE_534 | |
| Computational | Genes in the cancer module 222. | 1.31e-05 | 22 | 73 | 4 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 1.31e-05 | 22 | 73 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 1.57e-05 | 23 | 73 | 4 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 2.61e-05 | 26 | 73 | 4 | MODULE_127 | |
| Computational | Chromatin. | 3.54e-05 | 28 | 73 | 4 | MODULE_421 | |
| Computational | Genes in the cancer module 249. | 4.22e-04 | 22 | 73 | 3 | MODULE_249 | |
| Computational | Neighborhood of HDAC2 | 5.95e-04 | 280 | 73 | 8 | MORF_HDAC2 | |
| Drug | Methylmethacrylate | 4.29e-13 | 39 | 120 | 9 | ctd:D020366 | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | H2BC11 CWH43 SPTLC2 PCLO RAB11FIP1 H2BC17 H2BC21 H2BC5 H2BC12 | 5.85e-07 | 184 | 120 | 9 | 2696_UP |
| Drug | Berberine | 1.27e-06 | 202 | 120 | 9 | ctd:D001599 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 3.53e-06 | 171 | 120 | 8 | 2723_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 6.32e-06 | 185 | 120 | 8 | 6945_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 7.11e-06 | 188 | 120 | 8 | 4545_DN | |
| Drug | Vitamin K 3 | PDXDC1 EPRS1 ADAM19 AQP11 KIF1B RAB11FIP1 RYR1 GGT1 H2BC12L MET H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 GLDC BUB1 H2BC3 HERC2 PCK1 | 8.11e-06 | 1249 | 120 | 20 | ctd:D024483 |
| Drug | Pyridoxal Phosphate | 8.77e-06 | 53 | 120 | 5 | DB00114 | |
| Drug | 4-amino-5-oxopentanoic acid | 1.00e-05 | 26 | 120 | 4 | CID000000742 | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.08e-05 | 199 | 120 | 8 | 5347_DN | |
| Disease | Disorder of eye | 2.31e-06 | 212 | 118 | 8 | C0015397 | |
| Disease | Inguinal hernia | 2.44e-06 | 287 | 118 | 9 | HP_0000023 | |
| Disease | Phosphoenolpyruvate carboxykinase deficiency | 1.59e-05 | 2 | 118 | 2 | C0268194 | |
| Disease | susceptibility to childhood ear infection measurement | 6.69e-05 | 171 | 118 | 6 | EFO_0007904 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 9.97e-05 | 60 | 118 | 4 | EFO_0021898 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 1.04e-04 | 23 | 118 | 3 | C1708353 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 1.13e-04 | 62 | 118 | 4 | EFO_0022263 | |
| Disease | brain volume measurement | 1.43e-04 | 595 | 118 | 10 | EFO_0006930 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.68e-04 | 128 | 118 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.68e-04 | 128 | 118 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.68e-04 | 128 | 118 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.68e-04 | 128 | 118 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.68e-04 | 128 | 118 | 5 | C0007134 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.94e-04 | 132 | 118 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | Drugs affecting bone structure and mineralization use measurement | 2.11e-04 | 29 | 118 | 3 | EFO_0009936 | |
| Disease | Adult neuronal ceroid lipofuscinosis | 2.35e-04 | 6 | 118 | 2 | cv:C0022797 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.91e-04 | 224 | 118 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.98e-04 | 225 | 118 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | melanoma (is_marker_for) | 3.12e-04 | 33 | 118 | 3 | DOID:1909 (is_marker_for) | |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 3.29e-04 | 7 | 118 | 2 | EFO_0008119 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.29e-04 | 148 | 118 | 5 | C0279702 | |
| Disease | neuroimaging measurement | PDXDC1 KIF1B BBS9 NRP2 ENO4 H2BC4 CELF1 WNT16 MITF ADAMTS18 PDXDC2P FAM53B RAPGEF2 | 3.56e-04 | 1069 | 118 | 13 | EFO_0004346 |
| Disease | severe pre-eclampsia (is_marker_for) | 4.37e-04 | 8 | 118 | 2 | DOID:13129 (is_marker_for) | |
| Disease | NRF2 measurement | 4.37e-04 | 8 | 118 | 2 | EFO_0009794 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 5.60e-04 | 9 | 118 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | Neuronal ceroid lipofuscinosis | 5.60e-04 | 9 | 118 | 2 | cv:C0027877 | |
| Disease | uveitis | 5.60e-04 | 9 | 118 | 2 | EFO_1001231 | |
| Disease | premature birth | 5.60e-04 | 9 | 118 | 2 | EFO_0003917 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 5.84e-04 | 95 | 118 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 6.08e-04 | 96 | 118 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | Epilepsy, Myoclonic, Infantile | 6.99e-04 | 10 | 118 | 2 | C0917800 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 8.21e-04 | 104 | 118 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | non-alcoholic fatty liver disease | 8.42e-04 | 182 | 118 | 5 | EFO_0003095 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 8.52e-04 | 11 | 118 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 8.82e-04 | 106 | 118 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 9.13e-04 | 107 | 118 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | frontal fibrosing alopecia | 9.46e-04 | 48 | 118 | 3 | EFO_0009855 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.01e-03 | 110 | 118 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.01e-03 | 110 | 118 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.13e-03 | 51 | 118 | 3 | EFO_0022302 | |
| Disease | complement C4 measurement | 1.19e-03 | 52 | 118 | 3 | EFO_0004984 | |
| Disease | skin and soft tissue Staphylococcus aureus infection | 1.20e-03 | 13 | 118 | 2 | EFO_1001489 | |
| Disease | atopic asthma | 1.25e-03 | 199 | 118 | 5 | EFO_0010638 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 1.26e-03 | 53 | 118 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 1.26e-03 | 53 | 118 | 3 | EFO_0022258 | |
| Disease | metabolic syndrome | 1.28e-03 | 200 | 118 | 5 | EFO_0000195 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.33e-03 | 54 | 118 | 3 | EFO_0022244 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 1.40e-03 | 14 | 118 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 1.40e-03 | 14 | 118 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | caudate volume change measurement | 1.40e-03 | 14 | 118 | 2 | EFO_0021491 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 1.48e-03 | 56 | 118 | 3 | EFO_0022316 | |
| Disease | MMR-related febrile seizures | 1.61e-03 | 15 | 118 | 2 | EFO_0006519 | |
| Disease | triglycerides to total lipids in small LDL percentage | 1.72e-03 | 59 | 118 | 3 | EFO_0022337 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.72e-03 | 59 | 118 | 3 | EFO_0022260 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.76e-03 | 215 | 118 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | liver fat measurement, liver disease biomarker | 1.83e-03 | 16 | 118 | 2 | EFO_0006845, EFO_0010821 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.83e-03 | 16 | 118 | 2 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.83e-03 | 16 | 118 | 2 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.83e-03 | 16 | 118 | 2 | 415000 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.99e-03 | 62 | 118 | 3 | EFO_0022339 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 1.99e-03 | 62 | 118 | 3 | EFO_0022306 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 2.07e-03 | 17 | 118 | 2 | C2936862 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 2.08e-03 | 63 | 118 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 2.08e-03 | 63 | 118 | 3 | EFO_0022292 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 2.17e-03 | 64 | 118 | 3 | EFO_0022253 | |
| Disease | Intellectual Disability | 2.18e-03 | 447 | 118 | 7 | C3714756 | |
| Disease | phospholipids:total lipids ratio | 2.23e-03 | 227 | 118 | 5 | EFO_0020946 | |
| Disease | Bardet-Biedl syndrome | 2.33e-03 | 18 | 118 | 2 | cv:C0752166 | |
| Disease | squamous cell carcinoma | 2.48e-03 | 67 | 118 | 3 | EFO_0000707 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 2.48e-03 | 67 | 118 | 3 | EFO_0022245 | |
| Disease | triglycerides in very small VLDL measurement | 2.59e-03 | 68 | 118 | 3 | EFO_0022144 | |
| Disease | fatty acid measurement, linoleic acid measurement | 2.59e-03 | 68 | 118 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | triglycerides to phosphoglycerides ratio | 2.59e-03 | 68 | 118 | 3 | EFO_0022327 | |
| Disease | hepatitis B virus infection | 2.59e-03 | 19 | 118 | 2 | EFO_0004197 | |
| Disease | triglyceride measurement, phospholipid measurement | 2.85e-03 | 146 | 118 | 4 | EFO_0004530, EFO_0004639 | |
| Disease | polymyositis | 2.87e-03 | 20 | 118 | 2 | EFO_0003063 | |
| Disease | metabolite measurement, diet measurement | 2.92e-03 | 71 | 118 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 2.92e-03 | 71 | 118 | 3 | EFO_0022259 | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.04e-03 | 72 | 118 | 3 | EFO_0022336 | |
| Disease | phospholipids in large HDL measurement | 3.16e-03 | 73 | 118 | 3 | EFO_0022190 | |
| Disease | Immunosuppressant use measurement | 3.17e-03 | 21 | 118 | 2 | EFO_0009934 | |
| Disease | total lipids in large HDL | 3.29e-03 | 74 | 118 | 3 | EFO_0022189 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 3.29e-03 | 74 | 118 | 3 | EFO_0022280 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 3.41e-03 | 75 | 118 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 3.41e-03 | 75 | 118 | 3 | EFO_0022287 | |
| Disease | cholesteryl ester measurement | 3.80e-03 | 257 | 118 | 5 | EFO_0010351 | |
| Disease | Huntington's disease (is_implicated_in) | 3.80e-03 | 23 | 118 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 3.81e-03 | 78 | 118 | 3 | EFO_0022187 | |
| Disease | asthma, allergic disease | 3.95e-03 | 79 | 118 | 3 | MONDO_0004979, MONDO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CMRPAKSLMSISNAG | 781 | Q4VCS5 | |
| GCSSITFPKMMGKAS | 426 | Q9Y6F8 | |
| DGCSSITFPKMMGKA | 426 | Q9Y6F7 | |
| PQKMMGNIAAVAASC | 841 | Q9NP73 | |
| MSGAPTAGAALMLCA | 1 | Q9BY76 | |
| MITSKSNPGNNMACI | 171 | O43683 | |
| AAGKMASAACSMDPI | 6 | Q68CJ9 | |
| MTAGKCIGAIAMTEP | 161 | P28330 | |
| FIMFSSGTTGAPKCM | 286 | Q86V21 | |
| LQSGGGMCLSNMPDT | 396 | Q9H013 | |
| AQTMEGCSSPMVVKF | 171 | Q92879 | |
| GMDVLCQAKSGMGKT | 81 | O00148 | |
| GFSAMAKTVGLPTAM | 866 | Q9UDR5 | |
| MMCGAPSATQPATAE | 1 | P04080 | |
| SKGGSCPSRAKMSMT | 121 | Q96KQ7 | |
| CPSRAKMSMTGAGKS | 126 | Q96KQ7 | |
| GSMLPVSCKLPNMGT | 571 | Q8TAM1 | |
| PDTGISSKAMGIMNS | 51 | P57053 | |
| EGNMCKKSEGNIMSP | 446 | Q8TE57 | |
| KFMPAAEGTVCGLSM | 556 | Q8TE60 | |
| SACGKTNLAMMNPSL | 286 | P35558 | |
| PTSEANCSAMFGKLM | 526 | Q29RF7 | |
| KMDVPTGSGTCLMDS | 636 | O75916 | |
| PDTGISSKAMGIMNS | 51 | Q16778 | |
| PDTGISSKAMGIMNS | 51 | Q5QNW6 | |
| PDTGISSKAMGIMNS | 51 | P06899 | |
| PDTGISSKAMGIMNS | 51 | Q99877 | |
| CITVKNPAVMMGAEG | 156 | Q9P2P5 | |
| CKMSGLVQGMSVSAS | 116 | Q9GZQ6 | |
| TTMTVMATGAPCSAG | 1176 | P51610 | |
| PDTGISSKAMGIMNS | 51 | Q99879 | |
| TVAMCAPSEKFLNMG | 231 | Q9H3K2 | |
| NDSTLFTLAKMMPGC | 316 | P13196 | |
| QMCAKMSSFGPDSLL | 4446 | O95714 | |
| LCKMSDTGSPGMQRR | 1446 | O60333 | |
| KNGKSLPFMLCDTMG | 251 | Q53G44 | |
| APKGMSQLITMACGS | 151 | P80404 | |
| GPFTGIACGKSMMSS | 1446 | O75197 | |
| PDTGISSKAMGIMNS | 51 | P58876 | |
| PDTGISSKAMGIMNS | 51 | Q93079 | |
| PDTGISSKAMGIMNS | 51 | O60814 | |
| SMASICPTDGVKGMD | 481 | Q9NZ08 | |
| KMSQGPTLFSCGIME | 31 | Q14153 | |
| GIGGMKPSMSDTNLA | 2986 | Q9Y6V0 | |
| AFPSACGKTNLAMMR | 301 | Q16822 | |
| SLIQTGLAMAMPLCG | 156 | Q8NGV0 | |
| VLAAAKCDSMTMTPG | 286 | Q6P996 | |
| VLAAAKCDSMTMTPG | 286 | Q6P474 | |
| GTNCMASGSITPLPM | 511 | Q9ULK4 | |
| DAPCSNMLGMLSGLI | 431 | O60462 | |
| KGSCSSDPMLEGCRM | 471 | A0A1B0GTW7 | |
| NSCSMPLGMESKAIS | 2191 | P00451 | |
| LQDSLGGNSKTMMCA | 306 | Q9Y496 | |
| GGNSKTMMCANIGPA | 311 | Q9Y496 | |
| TTMVCVAVNGKPMLG | 191 | Q9NX62 | |
| AAAPQTMVMPGGCTT | 831 | Q3SYG4 | |
| MCSSMGTHLSPFKGT | 116 | Q6MZN7 | |
| GLSKMEQNGIMSTAC | 166 | Q96NX5 | |
| KMVPTMQDCSGSRSQ | 531 | Q8IUC8 | |
| KNCMSITMGSVRPSV | 991 | Q9UHC9 | |
| MGDSCCNPLSMGAIK | 41 | P50897 | |
| PDTGISSKAMGIMNS | 51 | P33778 | |
| PDTGISSKAMGIMNS | 51 | P62807 | |
| PDTGISSKAMGIMNS | 51 | Q8N257 | |
| STVMFPKIMGGASAN | 486 | Q9Y232 | |
| PEGTCINNTSVMMFK | 321 | Q86UL3 | |
| AGKTLCLSGFMGMDI | 361 | P07339 | |
| PDTGISSKAMGIMNS | 51 | Q99880 | |
| PDTGISSKAMGIMNS | 51 | P23527 | |
| LPGGSCMTALTVTLM | 6 | P01911 | |
| MEIPMGTQGCFSKSL | 1 | Q7Z692 | |
| KLPMVTVAMACSGAL | 266 | Q96A59 | |
| NTSMEASPKAGVGMA | 316 | Q8IWC1 | |
| MCGNTMSVPLLTDAA | 1 | O95372 | |
| MPLLMVSLVSCGKSS | 276 | A6NNW6 | |
| GGVCHSDPKMTSNML | 511 | Q6P179 | |
| LGSTMMTSACTNIPG | 61 | A0A0U1RQI7 | |
| MEMCTKGLGAQTGVL | 1251 | Q14689 | |
| CTPGRMIDMLAANSG | 501 | Q7L014 | |
| LMPASEMEKSGSCIG | 466 | P51530 | |
| MISACKGETGAMVSS | 3781 | P21817 | |
| MGVTCVSQMPVAEGK | 1 | Q9H944 | |
| GLELNCPSMGENTMK | 396 | Q9BVI0 | |
| INSGTNPGKTMTIAM | 306 | Q9H720 | |
| ESTMNTLKCTVGPAM | 616 | P08581 | |
| MGAPASGNMSTLQKT | 416 | Q8NET4 | |
| QLTMAKTSGAMPTGS | 466 | Q8NET4 | |
| TASGVMSCPQMRSLA | 596 | Q8NET4 | |
| PMNAMATKVANCSLG | 1181 | Q6WKZ4 | |
| AAAAMSLGPMGSVVK | 361 | P41225 | |
| KIDMSSNNGCMRDPT | 341 | P07814 | |
| SMAKPIGLCMPNSAH | 211 | Q96KN7 | |
| TAPHCMESSKSGMPG | 176 | Q9ULS5 | |
| TMPSNACFASMGSIG | 166 | Q96HU1 | |
| VRKGCQSLPSNMMET | 436 | Q9H0K1 | |
| TSALMGACVTASAMP | 401 | Q5C9Z4 | |
| MEGKGDVMSTACGTP | 171 | Q8IU85 | |
| GKLKPSGMMCGSDSE | 616 | Q6Q759 | |
| MAASCVLLHTGQKMP | 1 | P14550 | |
| LTLVGTSSNPCGVMM | 91 | Q8NBQ7 | |
| PSKTESMFMAGGSDC | 491 | Q9ULP9 | |
| EILCMGNSFGVSPTM | 191 | Q9Y4G8 | |
| LCSMVAKNSKAAGGP | 1761 | O15417 | |
| TTTVRKIMNCGGFGM | 381 | Q9P2U8 | |
| SGMVCPIIVGAMTKN | 456 | Q9P2U8 | |
| NCMSFANVGMSGLSP | 1041 | Q15468 | |
| MSSPLSQAKIMQTGG | 1436 | Q9BX84 | |
| PMAMLTLNSNCEKEG | 181 | O75030 | |
| TSMKCIMGQDGTSLG | 421 | O15270 | |
| MAPAGMSGAQDNSCL | 1 | Q6RVD6 | |
| SSPVCGSGMTSLLMN | 881 | Q92626 | |
| GGLTNLSKMPACNIM | 236 | Q8WWY3 | |
| MMKTLSSGNCTLSVP | 1 | Q96D21 | |
| PTAGCASLAKEMFAM | 86 | Q969D9 | |
| NCMITAAATTAPMGA | 91 | Q9UBV4 | |
| MPIMLRSSNCVLTGK | 136 | Q9NW08 | |
| GMMCSLSEQGKQLAI | 236 | Q9ULI2 | |
| PNGDMGSMVCKTTGT | 216 | Q86WI1 | |
| AALAGGITMVCAMPN | 1491 | P27708 | |
| MARKFSAPGQLCISM | 2281 | Q9H4A3 | |
| TKQMLPSSITMSQGG | 371 | O94842 | |
| MAVGLCKAMSQGLVT | 1 | Q8NB42 | |
| GKQPLSSMCPTIMVG | 446 | P19440 | |
| SMIPLGSCTMKLNSS | 551 | P23378 | |
| GGRTTMKSVVCKMNP | 1691 | Q8IZF0 | |
| RPGNTVKLNCMAMGI | 2746 | Q9NR99 | |
| MGVCSGKPGMVFSIS | 851 | Q13224 |